The novel coronavirus and the flu: How to to tell the difference, according to an expert
How can I tell the difference between the flu and COVID-19? — FOX News
Health Care, News Now!
Category: Health Care
How are you feeling today? Keep up to date on news and stories related to health care here!
Health Care, News Now!
Covid-19 Live updates: Johnson & Johnson tests one-shot vaccine
Johnson & Johnson plans to enroll 60,000 participants in its Phase 3 trials. Dr. Anthony Fauci and other top U.S. health officials are scheduled to testify before a Senate panel today. — NYT: Top Stories
Business, Health Care
Immetas Therapeutics announces Series A financing to advance research on inflammation pathways in aging and develop therapeutics for cancer and inflammatory disease
Immetas Therapeutics Announces Series A Financing to Advance Research on Inflammation Pathways in Aging and Develop Therapeutics for Cancer and Inflammatory Disease, EAST HANOVER, N.J.–(BUSINESS WIRE)–Immetas Therapeutics today announced it has raised a Series A financing of $11 million to advance research
Health Care, News Now!
We’ve hit 200,000 COVID deaths in 6 months. What will the next 6 months look like?
Experts weigh in on what the future may hold amid the pandemic. — ABC News: Top Stories
Health Care, News Now!
Woman, 102, beats coronavirus after surviving cancer, 1918 flu pandemic
The novel coronavirus was apparently no match for a 102-year-old woman in New Hampshire. FOX News: Madeline Farber
Health Care, News Now!
Live Covid-19 updates
Clinical trials have not included children, so vaccines for them may not arrive until the next school year, while adults may get theirs by summer. — NYT: Top Stories
Business, Health Care
Pathline Labs doubles testing capacity for COVID-19, adds major clients throughout U. S.
Pathline Labs Doubles Testing Capacity for COVID-19, Adds Major Clients Throughout U.S., Testing through Pathline Labs is now available nationwide RAMSEY, N.J.–(BUSINESS WIRE)–Pathline Labs, a leading provider of sub-specialized anatomic pathology, has expanded its COVID-19 testing capabilities across the country while maintaining
Health Care, News Now!
Covid-19 news: Live updates
The staggering toll of the pandemic comes as at least 73 countries are seeing surges in newly detected cases. — NYT: Top Stories
Business, Health Care
LYNPARZA reduced risk of death by 31% vs. Enzalutamide or Abiraterone for men with BRCA1/2 or ATM-mutated metastatic castration resistant prostate cancer who progressed following enzalutamide or abiraterone in Phase 3 PROfound trial
LYNPARZA is the Only PARP Inhibitor to Demonstrate Improved Overall Survival in Metastatic Castration-Resistant Prostate Cancer KENILWORTH, N.J.–(BUSINESS WIRE)–$MRK #MRK–AstraZeneca and Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced final results from the Phase 3 PROfound